Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

2.
3.
5.

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.

Spyratos F, Ferrero-Poüs M, Trassard M, Hacène K, Phillips E, Tubiana-Hulin M, Le Doussal V.

Cancer. 2002 Apr 15;94(8):2151-9. Review.

6.

Malignant granular cell tumor of soft tissue: diagnostic criteria and clinicopathologic correlation.

Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG.

Am J Surg Pathol. 1998 Jul;22(7):779-94. Erratum in: Am J Surg Pathol 1999 Jan;23(1):136.

PMID:
9669341
7.

Cytological grading of breast cancer in Giemsa-stained fine needle aspiration smears.

Skrbínc B, Babic A, Cúfer T, Us-Krásovec M.

Cytopathology. 2001 Feb;12(1):15-25.

PMID:
11256933
8.

Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.

Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA.

Cancer. 2004 Oct 15;101(8):1745-59.

9.

Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis.

Taniguchi E, Yang Q, Tang W, Nakamura Y, Shan L, Nakamura M, Sato M, Mori I, Sakurai T, Kakudo K.

Acta Cytol. 2000 Jul-Aug;44(4):587-91.

PMID:
10934952
10.

Biological indicators of aggressiveness in T1 ductal invasive breast cancer.

Bucci B, Carico E, Rinaldi A, Froio F, Puce YM, D'Agnano I, Vecchione A, Brunetti E.

Anticancer Res. 2001 Jul-Aug;21(4B):2949-55.

PMID:
11712792
11.

Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.

Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M.

Gynecol Oncol. 1999 Mar;72(3):331-6.

PMID:
10053103
12.

Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.

Crisi GM, Mandavilli S, Cronin E, Ricci A Jr.

Am J Surg Pathol. 2003 Mar;27(3):325-33.

PMID:
12604888
14.

Correlation between nuclear grade and biological prognostic variables in invasive breast cancer.

Yang Q, Mori I, Sakurai T, Yoshimura G, Suzuma T, Nakamura Y, Nakamura M, Taniguchi E, Tamaki T, Umemura T, Kakudo K.

Breast Cancer. 2001;8(2):105-10.

PMID:
11342982
15.

Mammary carcinoma: DNA analysis in areas showing different histological features in the same tumor.

Erhardt K, Auer G.

Acta Pathol Microbiol Immunol Scand A. 1986 Jan;94(1):21-8.

PMID:
3515846
16.

Flow cytometric DNA analysis of invasive carcinomas detected by screening mammography: use of specimen mammography-guided fine-needle aspirates.

Stomper PC, DeBloom JR 2nd, Levine E, Budnick RM, Stewart CC.

Clin Cancer Res. 1998 Jul;4(7):1789-95.

17.

[Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].

Moureau-Zabotto L, Bouchet C, Cesari D, Uzan S, Lefranc JP, Antoine M, Genestie C, Deniaud-Alexandre E, Bernaudin JF, Touboul E, Fleury-Feith J.

Cancer Radiother. 2005 Dec;9(8):575-86. Epub 2005 Oct 20. French.

PMID:
16243560
18.

Optimal management of ductal carcinoma in situ of the breast.

Sakorafas GH, Farley DR.

Surg Oncol. 2003 Dec;12(4):221-40. Review.

PMID:
14998563
19.

Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.

Auer G, Eriksson E, Azavedo E, Caspersson T, Wallgren A.

Cancer Res. 1984 Jan;44(1):394-6.

20.

Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics.

Steck K, Hunt K, Tucker S, Singletary S, El-Naggar AK.

Oncol Rep. 1999 Jul-Aug;6(4):835-8.

PMID:
10373666
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk